Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury

被引:45
作者
Fock, J
Galea, MP
Stillman, BC
Rawicki, B
Clark, M
机构
[1] Brighton Rehabil Ctr, Brighton, Vic 3186, Australia
[2] Univ Melbourne, Sch Physiotherapy, Parkville, Vic 3010, Australia
[3] Monash Univ, Dept Math & Stat, Clayton, Vic 3168, Australia
关键词
D O I
10.1080/0269905031000149498
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Primary objective : The aim of this study was to assess the effect of Botulinum toxin A in the management of spastic equinus resulting from traumatic brain injury. Research design : A before-after intervention design was used without controls. Methods and procedures : Subjects were seven patients suffering from traumatic brain injury of average duration 14 (4-38) months as a result of motor vehicle trauma, who had spastic equinus interfering with gait. Experimental intervention : The patients were treated with injections of Botulinum toxin A into the spastic calf muscles: gastrocnemius, soleus and tibialis posterior. Assessments were made pre-injection and at 2 weeks and 3 months post-injection. Main outcome and results : At the end of the 3-month period, all patients showed a significant improvement in gait velocity, cadence and stride length. Conclusions : The findings suggest that Botulinum toxin A may be useful in the management of spastic equinus following traumatic brain injury.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 21 条
  • [1] *AM AC ORTH SURG, 1965, JOINT MOT METH MEAS, P68
  • [2] INTERRATER RELIABILITY OF A MODIFIED ASHWORTH SCALE OF MUSCLE SPASTICITY
    BOHANNON, RW
    SMITH, MB
    [J]. PHYSICAL THERAPY, 1987, 67 (02): : 206 - 207
  • [3] PHENOL NERVE BLOCK IN TREATMENT OF ACQUIRED SPASTIC HEMIPLEGIA IN UPPER LIMB
    BRAUN, RM
    HOFFER, MM
    MOONEY, V
    MCKEEVER, J
    ROPER, B
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1973, A 55 (03) : 580 - 585
  • [4] A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients
    Burbaud, P
    Wiart, L
    Dubos, JL
    Gaujard, E
    Debelleix, X
    Joseph, PA
    Mazaux, JM
    Bioulac, B
    Barat, M
    Lagueny, A
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03) : 265 - 269
  • [5] EFFECT OF TREATMENT WITH BOTULINUM TOXIN ON SPASTICITY
    DAS, TK
    PARK, DM
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1989, 65 (762) : 208 - 210
  • [6] TREATMENT OF CHRONIC LIMB SPASTICITY WITH BOTULINUM TOXIN-A
    DUNNE, JW
    HEYE, N
    DUNNE, SL
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 58 (02) : 232 - 235
  • [7] Glenn M., 1990, PRACTICAL MANAGEMENT, P227
  • [8] BOTULINUM TOXIN TREATMENT FOR LOWER-LIMB EXTENSOR SPASTICITY IN CHRONIC HEMIPARETIC PATIENTS
    HESSE, S
    LUCKE, D
    MALEZIC, M
    BERTELT, C
    FRIEDRICH, H
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (11) : 1321 - 1324
  • [9] Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients
    Hesse, S
    Krajnik, J
    Luecke, D
    Jahnke, MT
    Gregoric, M
    Mauritz, KH
    [J]. STROKE, 1996, 27 (03) : 455 - 460
  • [10] Botulinum toxin A in the treatment of spasticity: Functional implications and patient selection
    Pierson, SH
    Katz, DI
    Tarsy, D
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (07): : 717 - 721